Dorte Kinggaard Holm is a researcher at the University of Southern Denmark's Faculty of Health Sciences , Department of Clinical Research, and affiliated with the Research Unit of Clinical Immunology at Odense University Hospital (OUH). She actively contributes to clinical immunology, microbiology, and infectious disease research. Research Focus: Fecal Microbiota Transplantation (FMT), Hepatitis C elimination, tick-borne diseases, and cardiovascular allograft banking. Collaborations: Engaged in Nordic Microbiota Meeting, ISBT Barcelona 2024, and IPFA/PEI international workshops. Teaching: Conducts specialized courses on microbiological donor screening, cellular therapy, and vascular allograft production. Projects: Key participant in Emergency Room Testing for Hepatitis C and Eliminating Hepatitis C in Southern Denmark . Her recent publications focus on antimicrobial susceptibility testing, FMT applications in autoimmune disease, and tick-borne pathogen surveillance in blood donors. She emphasizes practical implementation of biobank systems and infection control in tissue grafts.
John Hintze serves as a Guest Researcher within the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, where he is actively engaged with the Glycomics Program. His research spans multiple biological disciplines with a central focus on protein glycosylation mechanisms and their physiological implications. Dr. Hintze's primary research interests encompass glycomics, O-linked glycosylation pathways, protein modification processes, and their roles in both health and disease states. His work investigates how specific glycosylation patterns affect protein structure, cellular function, and disease mechanisms across various biological systems including neurological pathways, endocrine regulation, and genetic disorders. This research has important implications for understanding congenital diseases and developing potential therapeutic approaches. Analysis of Dr. Hintze's publication record from 2018-2025 reveals a sophisticated research trajectory focused on O-glycosylation across diverse biological contexts. His work demonstrates how glycosylation affects neuronal function, hormone regulation, congenital disorders, and host-pathogen interactions. The research consistently employs advanced glycoproteomic techniques and isogenic cell models to precisely characterize glycosylation patterns and their functional consequences. Dr. Hintze maintains a robust collaborative network with prominent researchers including Clausen H., Schjoldager K.T., Vakhrushev S.Y., and Joshi H.J. His laboratory work is centered within the University of Copenhagen's Glycomics Program, where he utilizes cutting-edge proteomics methodologies to investigate the complex relationships between glycosylation patterns and biological function across multiple systems.
Kenn Holmbeck is an Associate Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on virology, particularly hepatitis C virus (HCV) and SARS-CoV-2, with expertise in viral evolution, immune responses, and vaccine development. He employs both in vitro systems and animal models to investigate viral pathogenesis and develop novel therapeutic approaches. Dr. Holmbeck's research encompasses viral evolution dynamics, immune evasion mechanisms, and vaccine platform development. His work on HCV includes studying intra-host viral evolution, antibody escape mechanisms, and developing the Norway rat hepacivirus as a model system. For SARS-CoV-2, he investigates antiviral resistance pathways and develops innovative vaccine platforms including intranasal and inactivated vaccines that induce robust cross-protective immunity. Analysis of Dr. Holmbeck's recent publications (2023-2025) reveals a cohesive research program focused on viral pathogenesis and translational vaccine development. His work demonstrates expertise across multiple viral systems with particular emphasis on understanding how viruses evolve under immune or drug pressure and leveraging this knowledge to develop effective countermeasures. Key themes include viral adaptation mechanisms, neutralizing antibody responses, and the development of vaccine platforms that induce durable and cross-reactive immune protection. Dr. Holmbeck maintains extensive collaborative networks across virology research, as evidenced by his co-authorship on numerous high-impact publications in journals including PLOS Pathogens, Journal of Hepatology, Hepatology, and EBioMedicine. His research likely involves securing competitive grants to support laboratory work on viral pathogenesis and vaccine development, with publications indicating active involvement in both basic and translational research projects. Based on publication patterns, Dr. Holmbeck leads or is a key member of a research team with capabilities spanning molecular virology, animal challenge studies, and vaccine evaluation. His laboratory likely includes facilities for viral culture, sequencing, neutralization assays, and small animal studies, supporting a comprehensive approach to understanding viral pathogenesis and developing effective interventions.
Rebecca Louise Miller is an Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. She leads research in the Glycomics Program, focusing on glycosaminoglycan (GAG) biology and engineering, with laboratory facilities at Blegdamsvej 3 in Copenhagen. Dr. Miller's research centers on glycosaminoglycans, which are sulfated polysaccharides that play critical roles in the extracellular matrix. Her work specifically investigates the "sulfation code" of GAGs and how it relates to their diverse biological functions including cell migration, anticoagulation, angiogenesis, inflammation, and normal growth and development. By using genetic engineering approaches with KO/KI of genes in CHO cells, her lab produces cell-derived libraries displaying distinct heparin, heparan sulfate, chondroitin sulfate, and dermatan sulfate on cell surfaces. This innovative approach enables the dissection of structure-function relationships and the development of homogeneous GAG molecules with targeted therapeutic properties. Her recent publications demonstrate a strong interdisciplinary focus spanning glycobiology, analytical chemistry, cardiovascular biology, neuroscience, and infectious disease research. The articles reveal a consistent theme of developing and applying advanced methodologies—including mass spectrometry and single-molecule imaging—to characterize complex glycan structures and their interactions. Her work bridges fundamental science with translational applications, particularly in developing next-generation glycan-based therapeutics with defined structures rather than the heterogeneous animal-derived mixtures currently used clinically. Dr. Miller maintains an active laboratory that combines molecular biology, biochemistry, and analytical approaches to tackle the challenges of GAG complexity. Her research has significant implications for developing precision glycotherapeutics with specific biological activities (anti-coagulant, anti-inflammatory, or anti-viral) based on precisely engineered sulfation patterns, potentially revolutionizing treatment approaches for numerous conditions.
Judith Margarete Gottwein is Professor at the Department of Immunology and Microbiology within the Faculty of Health and Medical Sciences at the University of Copenhagen, Denmark. She also serves as Afdelingslæge at the Copenhagen Hepatitis C Program (CO-HEP) in the Department of Infectious Diseases at Copenhagen University Hospital, Hvidovre. Her research group focuses on basic and translational virology, with long-term emphasis on hepatitis C virus (HCV) and more recent work on SARS-CoV-2. Medical Doctor Degree (MD), Heidelberg University (2001) Doctoral Degree (Dr. med.), Heidelberg University (2001) License to Practice Independently as a Medical Doctor in Germany (2003) License to Practice and License to Practice Independently as a Medical Doctor in Denmark (2005) Professor Gottwein's research spans virology with a focus on hepatitis C virus and SARS-CoV-2. Her team pioneered development of HCV cell culture systems for major genotypes and is developing whole virus inactivated HCV vaccine candidates. They study neutralizing antibodies, antiviral efficacy, and resistance mechanisms. Recent work includes development of a SARS-CoV-2 vaccine candidate and studies of antivirals against emerging variants. Her publication record shows a consistent focus on viral genetics, vaccine development, and antiviral resistance. Recent articles demonstrate her group's leadership in developing HCV vaccine candidates that induce cross-genotype neutralizing antibodies and in studying resistance mechanisms for both HCV and SARS-CoV-2 antivirals. The research combines molecular virology, immunology, and translational approaches to address pressing public health challenges. EASL Prizes (2007, 2009) International Symposium on Hepatitis C Virus and Related Viruses Prizes (2007, 2008, 2010) German Academic Scholarship Foundation Fellowship (1994-2001) Multiple invited presentations at major international conferences Professor Gottwein has supervised numerous students including 7 Master's students, 8 completed PhD students, and 6 ongoing PhD students. She has led research projects funded by Innovation Fund Denmark, Independent Research Foundation Denmark, The Carlsberg Foundation, The Novo Nordisk Foundation, and other major funding bodies. Her management experience includes establishing research facilities at CO-HEP that grew from 3 to over 50 members since 2005. She leads the CO-HEP research group at the University of Copenhagen, which has developed from a small team to a major virology research center with over 50 members. Her laboratory specializes in cell culture systems for HCV and SARS-CoV-2, vaccine development, and antiviral resistance studies. The group maintains extensive national and international collaborations with institutions across Europe, North America, and Asia.
Franciscus Winfred J van der Berg serves as an Associate Professor in the Department of Food Science at the University of Copenhagen's Faculty of Science, specializing in Ingredient and Dairy Technology. His academic appointment focuses on Advanced Chemometrics in Food Technology. Dr. van der Berg's educational background includes a PhD in Process Analysis and Chemometrics from the University of Amsterdam, a graduate program in Analytical Chemistry at the same institution, and a Civil Engineering degree in Laboratory Information and Automation from The Netherlands. His research interests span Data analysis , Chemometrics , Statistics , Mathematics , and Process Analytical Chemistry , with particular emphasis on vibrational spectroscopy for process monitoring and control. His recent publications demonstrate a strong focus on food structure analysis, particularly in dairy products like mozzarella cheese and milk powders. His work integrates advanced spectroscopic techniques with statistical modeling to understand food properties and processing challenges. Dr. van der Berg has published extensively with 152 research outputs including journal articles, book chapters, and conference presentations. Dr. van der Berg teaches courses in Design of Experiments and Optimization, Food Process Equipment, and Process Analytical Chemistry and Technology. His research addresses practical challenges in food processing through advanced data analysis techniques. His professional network shows collaborations across multiple countries, indicating international research partnerships focused on food science and technology applications.
Hannah Gilliam-Vigh serves as a Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen, specializing in nutritional immunology and metabolic disease research. Her work focuses on molecular mechanisms underlying diabetes and obesity, with emphasis on gastrointestinal tissue analysis. Her research program centers on transcriptomic and molecular profiling of intestinal, hepatic, and adipose tissues in metabolic disease contexts. Key investigations include hormone mRNA expression patterns (e.g., oxytocin, cholesin), mucosal landscape alterations in type 2 diabetes, and molecular responses to bariatric interventions like Roux-en-Y gastric bypass. Methodologically, she integrates advanced genomic techniques with clinical metabolic phenotyping. Analysis of her 2024-2025 publications reveals a cohesive research trajectory at the diabetes-obesity interface, particularly investigating peptide hormone systems (GLP-2, oxytocin) in gut metabolism. Her work demonstrates strong translational focus, connecting basic molecular findings to therapeutic applications in metabolic surgery and obesity pharmacotherapy, with significant contributions to understanding post-bariatric physiological adaptations.
Monika Hezareh Rothmann serves as a Guest Researcher at the Department of Public Health's Section of Environmental Health within the University of Copenhagen's Faculty of Health and Medical Sciences. Her work focuses on assessing health impacts of emerging environmental contaminants through advanced toxicological methodologies. Her research program centers on environmental genotoxicity, specifically investigating combustion exhaust products from sustainable biofuels (rapeseed methyl ester, hydrogenated vegetable oils) and microplastic particles. She utilizes sophisticated in vitro models including lung epithelial (A549), intestinal (Caco-2), and hepatic (HepG2) cell lines to evaluate cellular damage mechanisms and potential public health risks. Recent publications reveal consistent methodological approaches using combinatorial exposure systems and genotoxicity biomarkers. Her 2023 Mutagenesis study demonstrated dose-dependent DNA damage from biofuel emissions, while the 2022 Frontiers in Public Health article established concentration-response relationships for plastic-derived particles, contributing significantly to environmental risk assessment frameworks.
Henrik Løvendahl Jørgensen is a Clinical Professor at the Department of Clinical Medicine, Clinical Biochemistry, within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research spans multiple domains of clinical medicine with a particular focus on biochemistry, diabetes, cardiovascular risk factors, and surgical outcomes. He maintains an active research program with numerous publications in high-impact journals. Dr. Jørgensen's research interests encompass clinical biochemistry, diabetes pathophysiology, hip fracture outcomes, plasma proteome dynamics, bariatric surgery effects, and COVID-19 complications. His work often utilizes large Danish population registries and clinical databases, reflecting Denmark's strength in registry-based medical research. His studies frequently investigate relationships between biomarkers (such as vitamin D, cholesterol fractions, and inflammatory markers) and clinical outcomes across diverse patient populations. Analysis of his recent publications reveals a strong emphasis on translational research connecting laboratory findings with clinical outcomes. His work spans from basic biochemical investigations of plasma proteome rhythms to large-scale epidemiological studies examining mortality predictors in primary care populations. A notable pattern is his focus on vulnerable patient groups including elderly hip fracture patients, pregnant women with SARS-CoV-2 infection, and patients with metabolic disorders. Dr. Jørgensen collaborates extensively with researchers across multiple disciplines and institutions in Denmark, as evidenced by his co-authorship on studies involving endocrinology, orthopedics, infectious disease, and maternal-fetal medicine. His research demonstrates a commitment to improving clinical practice through evidence-based medicine, with several studies providing direct guidance for clinical decision-making in areas such as tranexamic acid use in hip fracture surgery and dexamethasone dosing in critically ill COVID-19 patients.
Jan-Wilhelm Kornfeld is Professor of Molecular Biology of Metabolic Disease at the University of Southern Denmark's Department of Biochemistry and Molecular Biology. He co-founded the ADIPOSIGN research center and leads investigations into noncoding RNA regulation of metabolic pathways, focusing on obesity and type 2 diabetes. His laboratory employs transgenic mouse models, next-generation sequencing, and in vivo RNA targeting to study how microRNAs and long noncoding RNAs control energy homeostasis. Current projects examine adipose tissue plasticity, intergenerational epigenetic inheritance of metabolic dysfunction, and RNA-based therapeutics. Key research themes include: Noncoding RNA regulation of glucose/lipid metabolism Adipose tissue remodeling in obesity Cold-induced thermogenesis Paternal epigenetic inheritance Major publications appear in Nature Metabolism, Nature Communications, and Cell Reports. His research has been recognized with an Emmy-Noether Programme Grant (2014) and ERC Starting Grant (2016). He directs the Kornfeld Lab, supervising PhD candidates and research staff in functional genomics approaches.
Maja Thiele is a Clinical Professor at the University of Southern Denmark , affiliated with the Department of Clinical Research and the Research unit of Medical Gastroenterology (Odense) . She is a practicing Medical Doctor at Odense University Hospital and an active radio host on Danmarks Radio P1's Sygt Nok show, covering health topics for public audiences. Education : PhD (2016), University of Southern Denmark Medical Doctor (2007), University of Copenhagen Research Interests focus on steatotic liver disease related to alcohol and metabolic dysfunction, emphasizing liver fibrosis , non-invasive biomarkers , elastography , and omics technologies . She employs meta-analysis , proteomics , and lipidomics to improve early detection, diagnosis, and prognosis of liver diseases. Scientific Trends in her recent peer-reviewed articles and editorials show a strong emphasis on transient elastography , biomarker validation (e.g., PRO-C3 , sTREM2 ), public health screening (e.g., LiverScreen project ), and policy research addressing alcohol-related harm. Her work bridges clinical hepatology and population-level interventions . Scientific Awards : Syddansk Universitets Innovationspris (2023) UEG Rising Star (2022) Klinisk Instituts Forskningskommunikationspris (2022) Research Communication prize (2019) Advising and Grants include coordinating major EU-funded projects like LIVERAIM (2024-2030) and DECIDE (2020-2025), with supervised research work (n=3). She has contributed to clinical guidelines referenced in 6 policy sources and 4 clinical guideline sources , while maintaining an active role in peer review and public science communication via 140+ media contributions and Twitter (45k followers).
Jesper Grud Skat Madsen is an Associate Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark (SDU), and Principal Investigator of the MadLab research group. His work bridges computational biology with experimental genomics, focusing on transcriptional regulation in tissue plasticity and metabolic diseases. Current affiliation: SDU (Department of Biochemistry and Molecular Biology) Previous affiliation: SDU (Department of Mathematics and Computer Science, 2021-2023) Research centers: ATLAS, Human Gene Regulatory Map (HGRM), ADIPOSIGN
Jan Wilhelm Kornfeld is a Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark, leading a research group focused on epigenetic regulation of energy metabolism in cardiometabolic diseases. After obtaining his PhD in Cell Biology from the Boltzmann Institute for Cancer Research (2008), he conducted postdoctoral research with Jens Brüning in Germany (2013), where he pioneered studies on obesity-associated microRNAs and hepatic insulin resistance. His independent research at CECAD (2013) and Max Planck Institute for Metabolism Research (2014) has been supported by prestigious grants including the Emmy-Noether Grant (2014) and ERC Starting Grant (2015). Education: PhD in Cell Biology, Boltzmann Institute for Cancer Research, Austria (2008) Postdoctoral Training, Jens Brüning Lab, Germany (2013) The Kornfeld Lab investigates epigenetic regulatory processes such as non-coding microRNAs (miRNA) and chromatin modifications that impact organismal, tissue, and cellular energy balance. Their research integrates molecular genomics , transgenic animal models , and inter-organ crosstalk to uncover disease-associated molecular signatures in obesity and type 2 diabetes (T2D). Key projects include miRNA perturbation in vivo, nutritional intervention strategies, and development of adeno-associated virus (AAV) gene therapy tools . Recent publications highlight work on dietary sulfur amino acid restriction , mitochondrial dysfunction in brown adipocytes, and miR-let-7 in intergenerational metabolic decline. His research spans transcriptional regulation , metabolomics , and non-coding RNA mechanisms in metabolic diseases. Scientific Awards: Emmy-Noether Grant (2014) ERC Starting Grant (2015) The lab actively trains Bachelor, Master, and ISA students in hypothesis-driven research, focusing on RNA-mediated gene regulation , chromatin dynamics , and (patho)physiological analysis . Collaborations with global experts and industrial partners enhance translational impact.
Uffe Vest Schneider serves as an Associate Professor and Part-time lecturer in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. His research spans virology and bacteriology with significant contributions to understanding viral pathogens, transmission dynamics, and immune responses. Dr. Schneider's research program focuses on critical areas of viral pathogenesis and public health. His work examines viral evolution mechanisms, particularly in hepatitis C virus hypervariable regions and SARS-CoV-2 variants, with emphasis on immune evasion strategies. He has developed innovative surveillance methodologies, including community-based self-sampling systems for monitoring respiratory viruses in Denmark. His bacteriology research complements his virology work, providing a comprehensive understanding of microbial pathogens. His publications demonstrate expertise across molecular virology, clinical epidemiology, and public health interventions. Analysis of Dr. Schneider's publication record reveals a strategic research trajectory addressing emerging viral threats. His work spans from fundamental molecular studies of viral evolution to population-level investigations of disease transmission and vaccine effectiveness. The 2025 publications on mpox transmission scenarios and hepatitis C virus mechanisms represent continuation of his focus on viral evolution, while the community-based surveillance system demonstrates practical application of his research to public health infrastructure. His 2023 SARS-CoV-2 studies covered the full spectrum from diagnostics to clinical outcomes, showcasing methodological diversity and interdisciplinary approach. Dr. Schneider's research has achieved significant visibility, with multiple publications being covered by news outlets, shared extensively on social media platforms (including thousands of X/Twitter mentions), and widely read on academic networks like Mendeley. His collaborative approach is evident in the large author lists on many publications, indicating strong national and international research partnerships. Based at Blegdamsvej 3B in Copenhagen, Dr. Schneider operates within one of Europe's leading institutions for medical research. His dual appointment structure suggests an intentional balance between research-intensive work as Associate Professor and teaching responsibilities as Part-time lecturer, contributing to both knowledge generation and academic training in microbiology and immunology.
Sam Trammell is an Assistant Professor in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. He works within the Grevengoed Group focusing on n-acyl taurines (NATs) and Fibroblast growth factor 21 (FGF21) research. His educational background includes a PhD in Genetics from the University of Iowa (2016) and a B.Sc. in Genetics from the University of Wisconsin-Madison (2009). Dr. Trammell's research focuses on two primary areas: N-acyl taurines (NATs) : Investigating these amphiphilic lipids as endogenously produced detergents, their role in cell signaling through GPR119, fat absorption, and how their concentration increases with dietary fish oil to levels comparable to bile acids Appetite regulation : Studying Fibroblast growth factor 21 (FGF21) as a macronutrient responsive hepatokine that regulates lipid metabolism and macronutrient preference His recent publications demonstrate expertise in metabolomics, mass spectrometry, and lipid metabolism, with particular emphasis on bile acids, hormone secretagogues, and molecular trafficking mechanisms. Scientific awards and honors include: 2018: Marion Dave Francis Innovator Award from the University of Iowa 2017: University of Iowa Graduate Dean's Distinguished Dissertation Prize for "Novel NAD+ Metabolomic Technologies and their Applications to Nicotinamide Riboside Interventions" 2012-2013: NSF grant MCB-0822581 and NIH Pre-Doctoral Training Program in Genetics T32 grant GM008629 Dr. Trammell has received significant attention for his research, with publications being picked up by multiple news outlets, blogged about, and shared across social media platforms including X (formerly Twitter) and Facebook. His work has garnered considerable attention in academic circles with numerous readers on Mendeley. His laboratory work utilizes advanced metabolomics techniques to investigate the relationship between small molecule metabolites and hormonal regulation, particularly focusing on how dietary components influence metabolic pathways.
